Atea Pharmaceuticals
AVIR
AVIR
69 hedge funds and large institutions have $2.07B invested in Atea Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 69 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
69
Holding in Top 10
9
Calls
–
Puts
–
Top Buyers
| 1 | +$269M | |
| 2 | +$260M | |
| 3 | +$235M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$224M |
| 5 |
PA
Perceptive Advisors
New York
|
+$130M |
Top Sellers
No sellers this quarter